logo-altasciences

EN - Main navigation

  • Proactive Drug Development
  • Solutions
  • Compare Us
  • Facilities
  • About Us
  • Resource Center
  • Careers
  • News & Events
  • Contact Us
  • Participate in a study
Français
  • Home
  • Current: Committed to Animal Welfare

COMMITTED TO ANIMAL WELFARE

 

We maintain an unwavering focus on the welfare of the laboratory animals in our care. Our entire preclinical staff is trained in laboratory animal care and focused on animal welfare and environmental enrichment — embracing compassion, sensitivity and adherence to regulatory guidelines.

Our methodologies, procedures and equipment are refined to decrease stress on the animals, improve workflows, and ensure the success of your study. As part of our C.A.R.E. program, which every employee has pledged to support, we are committed to the 3Rs (replacement, reduction and refinement). All efforts in this regard are overseen by our Chief Animal Welfare Officer, a member of the Altasciences executive team.

  • Animal Welfare Council consisting of members from several departments
  • C.A.R.E. Contract/Pledge — every employee has signed a contract prioritizing the humane care of animals used in research
  • Comprehensive environmental and animal enrichment program is supported by a dedicated team of enrichment staff lead by an NHP behaviorist
  • We promote and provide social housing configurations for all species
    • Dog kennels with interconnecting doors for additional socialization
    • Mini Pig habitat caging configured to allow for snout-to-snout interactions
  • Use of a humane endpoints policy to minimize pain and discomfort
  • Veterinary committee for decision-making in difficult euthanasia situations

Unique Handling, Animal Care and Housing

  • Passive restraint NHP procedure cages
  • EU-compliant group housing for NHPs
  • Consistent healthcare, welfare and enrichment from point of origin to final destination

Sign up for exclusive content

Join our list of 10,000+ VIP members and have access to our exclusive content.

Stay connected

  • linkedin
  • youtube

Footer

    • Solutions

      • Preclinical Services
      • Clinical Services
      • Manufacturing and Analytical Services
      • Bioanalytical Services
      • Research Support Services
      • Development Programs
    • News & Events

      • Altasciences Events
      • Press Releases
      • Altasciences in the News
      • Press Kit
    • Resource Center

      • The Altascientist
      • Webinars/Podcasts
      • Newsletters
      • Scientific Publications
      • Blog
      • Videos
    • Study Types

      • Preclinical
      • Lead Optimization
      • Pharmacology
      • Pharmacokinetics/​Pharmacodynamics
      • Acute Toxicology
      • Dose Range Finding​/​Maximum Tolerated Dose
      • Repeated Dose Toxicity
      • Safety Pharmacology
      • Sub-Chronic/Chronic, Repeated Dose Toxicity
      • Clinical
      • First in Human
      • Proof of Concept
      • Bioavailability/Bioequivalence
      • Pharmacokinetics in Special Populations
      • Human Abuse Potential
      • Driving Simulation
      • Drug-Drug Interaction
      • QT Assessment
      • Renal and Hepatic Impaired
      • Imaging
      • Biologics​/​Biosimilars
    • Therapeutic Areas

      • Cardiology
      • Dermatology
      • Gastroenterology
      • Hematology
      • Immunology
      • Infectious Diseases
      • Metabolism and Endocrinology
      • Neurology
      • Oncology
      • Ophthalmology
      • Orthopedics
      • Psychiatry
      • Respirology
      • Rheumatology
      • Substance Abuse
      • Urology
      • Women’s Health
    • About us

      • History
      • Our Origins
      • Awards
      • Testimonials
    • Careers

    • Contact Us

    • Locations

    • Stay connected

      • Facebook
      • Youtube

2025 © Altasciences. All Rights Reserved.

Cookie Policy | Privacy Policy

Have a question?

I'd be happy to help.

Captcha is required.